Search This Blog

Monday, August 10, 2026

Hims & Hers Health cuts top end of full-year adjusted EBITDA forecast after Q2 2026 results

 


  • Q2 2026 revenue $753.2M (+38% YoY), beating analyst estimates
  • Q2 2026 EPS -$0.37 (-318% YoY), missing analyst consensus estimates
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)